Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Remote monitoring codes: CMS released new cardiac remote monitoring-specific codes and payment rates in the 2009 1physician fee schedule issued Oct. 30. The current procedural technology codes, recently created by the American Medical Association, will contribute to a more "stable payment environment" for remote monitoring, says David Blaszczak, an analyst with the Stanford Group. Physicians have faced challenges in getting reimbursed for time spent reviewing information collected via remote devices such as cardiac monitors in part due to the absence of specific codes. Among the new codes are two for "mobile cardiovascular telemetry" that directly impact monitoring products made by CardioNet. Medicare has previously established specific CPT codes for remote analysis of pacemaker and implantable defibrillator data (2"The Gray Sheet" June 19, 2006, In Brief)

You may also be interested in...

CMS Offers New Path To Coverage For Preventive Services

CMS says a provision in recently passed Medicare legislation will allow more timely national coverage of preventive services

Remote monitoring payments

Beginning July 10, physicians should submit claims to CMS for remote electronic analysis of pacemakers and ICDs using four CPT codes published by the American Medical Association in 2005. Medtronic, Guidant and St. Jude had lobbied the AMA to establish the codes, which Medtronic says simplify physician billing. Remote monitoring systems for implantable cardiac devices include Medtronic's Carelink, Boston Scientific's Latitude and St. Jude's HouseCall Plus, but reimbursement is currently limited (1"The Gray Sheet" June 12, 2006, p. 5)...

QUOTED. 20 February 2020. Steven Raman.

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts